milrinone has been researched along with Critical Illness in 10 studies
Critical Illness: A disease or state in which death is possible or imminent.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with the PDE-III inhibitor milrinone improves hemodynamics in patients with heart failure." | 9.09 | Milrinone therapy in catecholamine-dependent critically ill patients with heart failure. ( Delle-Karth, G; Haumer, M; Heinz, G; Koller-Strametz, J; Koreny, M; Siostrzonek, P, 2000) |
"Treatment with the PDE-III inhibitor milrinone improves hemodynamics in patients with heart failure." | 5.09 | Milrinone therapy in catecholamine-dependent critically ill patients with heart failure. ( Delle-Karth, G; Haumer, M; Heinz, G; Koller-Strametz, J; Koreny, M; Siostrzonek, P, 2000) |
"Milrinone is a drug frequently used for hemodynamic support in children during critical illness." | 5.05 | The effect of milrinone on hemodynamic and gas exchange parameters in children. ( Dorsey, V; Flores, S; Loomba, RS; Villarreal, EG, 2020) |
" We hypothesized that milrinone administration would increase cardiac index (CI) and oxygen delivery (Do2) in ICU patients, and that a pharmacokinetic model previously developed in cardiac surgery patients may be used to predict milrinone plasma concentrations in a medical-surgical ICU population." | 2.68 | Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients. ( Butterworth, JF; Coursin, DB; Levy, JH; MacGregor, DA; Meredith, JW; Prielipp, RC; Wood, KE, 1996) |
"Milrinone is an inotropic drug used in a variety of clinical settings in adults and children." | 2.53 | Milrinone Dosing Issues in Critically Ill Children With Kidney Injury: A Review. ( Gist, KM; Goldstein, SL; Joy, MS; Vinks, AA, 2016) |
"Milrinone is an inotrope widely used for treatment of cardiac failure." | 2.53 | Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. ( Bekema, HJ; Gluud, C; Keus, F; Koster, G; van der Horst, IC; Wetterslev, J, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Loomba, RS | 1 |
Dorsey, V | 1 |
Villarreal, EG | 1 |
Flores, S | 1 |
Schindler, E | 1 |
Yamamoto, T | 1 |
Panchal, AK | 1 |
Manzi, J | 1 |
Connolly, S | 1 |
Christensen, M | 1 |
Wakeham, M | 1 |
Goday, PS | 1 |
Mikhailov, TA | 1 |
McNeilly, RG | 1 |
Greco, T | 1 |
CalabrĂ², MG | 1 |
Covello, RD | 1 |
Greco, M | 1 |
Pasin, L | 1 |
Morelli, A | 1 |
Landoni, G | 1 |
Zangrillo, A | 1 |
Gist, KM | 1 |
Goldstein, SL | 1 |
Joy, MS | 1 |
Vinks, AA | 1 |
Koster, G | 1 |
Bekema, HJ | 1 |
Wetterslev, J | 1 |
Gluud, C | 1 |
Keus, F | 1 |
van der Horst, IC | 1 |
Lindeborg, DM | 1 |
Pearl, RG | 1 |
Prielipp, RC | 1 |
MacGregor, DA | 1 |
Butterworth, JF | 1 |
Meredith, JW | 1 |
Levy, JH | 1 |
Wood, KE | 1 |
Coursin, DB | 1 |
Siostrzonek, P | 1 |
Koreny, M | 1 |
Delle-Karth, G | 1 |
Haumer, M | 1 |
Koller-Strametz, J | 1 |
Heinz, G | 1 |
5 reviews available for milrinone and Critical Illness
Article | Year |
---|---|
The effect of milrinone on hemodynamic and gas exchange parameters in children.
Topics: Blood Gas Analysis; Cardiac Output, Low; Cardiotonic Agents; Child; Critical Illness; Hemodynamics; | 2020 |
A Bayesian network meta-analysis on the effect of inodilatory agents on mortality.
Topics: Bayes Theorem; Cardiac Surgical Procedures; Critical Illness; Dobutamine; Enoximone; Humans; Hydrazo | 2015 |
Milrinone Dosing Issues in Critically Ill Children With Kidney Injury: A Review.
Topics: Acute Kidney Injury; Child; Critical Illness; Dose-Response Relationship, Drug; Humans; Metabolic Cl | 2016 |
Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
Topics: Adult; Critical Illness; Heart Diseases; Humans; Milrinone; Phosphodiesterase 3 Inhibitors; Randomiz | 2016 |
Inotropic therapy in the critically ill patient.
Topics: Amrinone; Cardiac Glycosides; Cardiotonic Agents; Catecholamines; Critical Illness; Enoximone; Human | 1993 |
2 trials available for milrinone and Critical Illness
Article | Year |
---|---|
Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Output; Critical Illness; Female; Hemodynamics; Humans; Male | 1996 |
Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
Topics: Aged; Cardiotonic Agents; Catecholamines; Critical Illness; Dobutamine; Drug Therapy, Combination; F | 2000 |
3 other studies available for milrinone and Critical Illness
Article | Year |
---|---|
New Drugs for Old Problems: Which Inotropes for Critically Ill Children?
Topics: Cardiac Output, Low; Child; Critical Illness; Dobutamine; Double-Blind Method; Humans; Milrinone; Pi | 2018 |
Safety of Enteral Feedings in Critically Ill Children Receiving Vasoactive Agents.
Topics: Adolescent; Cardiovascular Agents; Child; Child, Preschool; Critical Illness; Dobutamine; Dopamine; | 2016 |
Sepsis, venous return, and teleology.
Topics: Algorithms; Blood Pressure; Cardiac Output; Coronary Circulation; Critical Illness; Dihydroergotamin | 2014 |